Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4711 AL 4725

Interaction Between α-Synuclein and DJ-1 in Parkinson's Disease

Sobhifar P, Brown DR.

Brain Sci. 2025 Aug 22;15(9):899. doi: 10.3390/brainsci15090899.

Beyond the Eye: Glaucoma and the Brain

Zeppieri M, Visalli F, Musa M, Avitabile A, Giglio R, Tognetto D, Gagliano C, D'Esposito F, Cappellani F.

Brain Sci. 2025 Aug 28;15(9):934. doi: 10.3390/brainsci15090934.

Imaging of Cerebral Iron as an Emerging Marker for Brain Aging, Neurodegeneration, and Cerebrovascular Diseases

Zhou CH, Zhu YC.

Brain Sci. 2025 Aug 29;15(9):944. doi: 10.3390/brainsci15090944.

Unraveling the Mystery of Hemoglobin in Hypoxia-Accelerated Neurodegenerative Diseases

Tian Z, Jin F, Geng Z, Xu Z, Shao Q, Liu G, Ji X, Liu J.

Biomolecules. 2025 Aug 25;15(9):1221. doi: 10.3390/biom15091221.

Dopaminergic and Noradrenergic Contributions to Divergent and Convergent Creativity Task Performance, a Systematic Review

Beversdorf DQ.

Behav Sci (Basel). 2025 Aug 30;15(9):1185. doi: 10.3390/bs15091185.

Druggability of Sodium Calcium Exchanger (NCX): Challenges and Recent Development

Scognamiglio A, Corvino A, Caliendo G, Fiorino F, Perissutti E, Santagada V, Severino B.

Int J Mol Sci. 2025 Sep 12;26(18):8888. doi: 10.3390/ijms26188888.

Neuroactive Phytochemicals as Multi-Target Modulators of Mental Health and Cognitive Function: An Integrative Review

Tkaczenko H, Buyun L, Kołodziejska R, Kamiński P, Kurhaluk N.

Int J Mol Sci. 2025 Sep 12;26(18):8907. doi: 10.3390/ijms26188907.

Orexin and Lifestyle Habits: A Meaningful Connection Among Nutrition, Physical Activity, and Sleep Pattern in Health and Diseases

Nigro E, Argentino F, Musumeci G, Daniele A.

Int J Mol Sci. 2025 Sep 15;26(18):8980. doi: 10.3390/ijms26188980.

Regulation of NR4A2 Gene Expression and Its Importance in Neurodegenerative and Psychiatric Diseases

Ruiz-Sánchez E, Rojas C, Yescas Gómez P, Martínez-Rodríguez N, Ruiz-Chow ÁA, Nava-Ruiz C, Ibáñéz-Cervantes G, Arciniega-Martínez IM, Reséndiz-Albor AA, Rojas P.

Int J Mol Sci. 2025 Sep 19;26(18):9162. doi: 10.3390/ijms26189162.

Nanomedicine-Driven Modulation of the Gut-Brain Axis: Innovative Approaches to Managing Chronic Inflammation in Alzheimer's and Parkinson's Disease

Krsek A, Schleicher LMS, Jagodic A, Baticic L.

Int J Mol Sci. 2025 Sep 19;26(18):9178. doi: 10.3390/ijms26189178.

The Role of Prenatal Microglial Activation and Its Sex Differences in the Development of Neuropsychiatric Disorders and Neurodegenerative Diseases

Lyamtsev AS, Sentyabreva AV, Kosyreva AM.

Int J Mol Sci. 2025 Sep 22;26(18):9250. doi: 10.3390/ijms26189250.

Functionalized Magnetic Nanoparticles: Can They Revolutionize the Treatment of Neurodegenerative Disorders?

Zahariev N, Boyuklieva R, Penkov D, Lukova P, Katsarov P.

Materials (Basel). 2025 Sep 14;18(18):4302. doi: 10.3390/ma18184302.

Beyond the Cardio-Renal-Metabolic Axis: Emerging Therapeutic Targets and Novel Mechanisms of Action of Flozins

Matuszewski W, Tomaszek L, Szklarz M, Górny JM, Kordas B, Rutkowska J, Juranek J.

J Clin Med. 2025 Sep 9;14(18):6348. doi: 10.3390/jcm14186348.

Ocular Surface Changes Associated with Neurological Diseases

Zemaitiene R, Gorgadze G, Mockaitiene L.

Medicina (Kaunas). 2025 Sep 18;61(9):1693. doi: 10.3390/medicina61091693.

AZP2006 in Progressive Supranuclear Palsy: Outcomes from a Phase 2a Multicenter, Randomized Trial, and Open-Label Extension on Safety, Biomarkers, and Disease Progression

Corvol JC, Obadia MA, Moreau C, Mariani LL, Brandel JP, Devos D, Sambin S, Carrière N, Höglinger G, Lebouteux M, Mangone G, Callizot N, Blondel A, Defert O, Estrella C, Karapet A, Verwaerde P, Defebvre L.

Mov Disord. 2025 Dec;40(12):2700-2709. doi: 10.1002/mds.70049. Epub 2025 Sep 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias